「实战经验分享」真实世界之ALK重排诊疗( 六 )

[2] Soda M, Isobe K, Inoue A, Maemondo M, Oizumi S, et al. (2012) A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non-Small Cell Lung Cancer. Clin Cancer Res 11: 11.

[3]中国间变性淋巴瘤激酶阳性、ROS1阳性非小细胞肺癌诊疗指南(2018年版). 中华病理学杂志. 2018,47(4):241-247.

[4] Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer. N Engl J Med 2017; 377:829-838.

[5] M. I. Ilie1,2, C. Bence1, V. Hofman1,2,3, E. Long-Mira1,2, C. Butori1, L. Bouhlel4, S. Lalvée1,J. Mouroux2,5, M. Poudenx4, J. Otto6, C. H. Marquette2,4 & P. Hofman1,2,3*

[6] Journal of Thoracic Oncology, March 2014, Volume 9, Issue 3, e21–e23

[7] Journal of Thoracic Oncology, January 2017, Volume 12, Issue 1, 94-101